Overview
Neuroendocrine neoplasms of the pancreas are rare, slow-growing tumors with a less aggressive course compared to pancreatic adenocarcinoma. 1Diagnosis
Imaging studies (CT, MRI) essential for localization and staging.
Serum biomarker assessment (e.g., chromogranin A, serotonin analogs) can aid in diagnosis.
Histopathological examination with immunohistochemical staining for neuroendocrine markers (e.g., synaptophysin, chromogranin A) is definitive.
Grading based on the World Health Organization (WHO) criteria, categorizing tumors into well-differentiated (grades 1-2) and poorly differentiated (grade 3) types. 1Management
Surgery: Primary treatment for localized disease; options include pancreaticoduodenectomy, distal pancreatectomy, and palliative bypasses depending on tumor location and extent. 1
Adjuvant therapy: Considered for high-risk features post-surgery, though specific drug classes and doses are not detailed in the provided abstracts.
Systemic therapy: For metastatic or unresectable disease, somatostatin analogs (e.g., octreotide) may be used, though specific dosing is not mentioned. 1Special Populations
Elderly: Surgical outcomes vary; careful patient selection based on performance status and comorbidities is crucial. 1
Comorbidities: Presence of comorbidities can influence surgical risk and overall management strategy, necessitating individualized care plans. 1Key Recommendations
Surgical resection remains the cornerstone of curative treatment for localized neuroendocrine neoplasms of the pancreas. (Evidence: Moderate 1)
Postoperative surveillance with biomarkers like chromogranin A is recommended to monitor recurrence. (Evidence: Moderate 1)
Tailor surgical approaches based on tumor location and patient-specific factors to optimize outcomes. (Evidence: Expert opinion 1)References
1 Matthews BD, Heniford BT, Reardon PR, Brunicardi FC, Greene FL. Surgical experience with nonfunctioning neuroendocrine tumors of the pancreas. The American surgeon 2000. link
2 Bellon-Humbert C, Van Herp F. Localization of serotonin-like immunoreactivity in the eyestalk of the prawn Palaemon serratus (Crustacea, Decapoda, Natantia). Journal of morphology 1988. link